Hehlmann, R
,
Lauseker, M
Saußele, S
Pfirrmann, M
Krause, S
Kolb, H J
Neubauer, A
Hossfeld, D K
Nerl, C
Gratwohl, A
Baerlocher, G M
Heim, D
Brümmendorf, T H
Fabarius, A
Haferlach, C
Schlegelberger, B
Müller, M C
Jeromin, S
Proetel, U
Kohlbrenner, K
Voskanyan, A
Rinaldetti, S
Seifarth, W
Spieß, B
Balleisen, L
Goebeler, M C
Hänel, M
Ho, A
Dengler, J
Falge, C
Kanz, L
Kremers, S
Burchert, A
Kneba, M
Stegelmann, F
Köhne, C A
Lindemann, H W
Waller, C F
Pfreundschuh, M
Spiekermann, K
Berdel, W E
Müller, L
Edinger, M
Mayer, J
Beelen, D W
Bentz, M
Link, H
Hertenstein, B
Fuchs, R
Wernli, M
Schlegel, F
Schlag, R
de Wit, M
Trümper, L
Hebart, H
Hahn, M
Thomalla, J
Scheid, C
Schafhausen, P
Verbeek, W
Eckart, M J
Gassmann, W
Pezzutto, A
Schenk, M
Brossart, P
Geer, T
Bildat, S
Schäfer, E
Hochhaus, A
Hasford, J
Article History
Received: 23 June 2017
Accepted: 4 July 2017
First Online: 14 August 2017
Competing interests
: RH received research support from Novartis and honoraria from BMS, SS research support from Novartis, BMS, Ariad and Pfizer, MP honoraria from Novartis and BMS, SK honoraria from Novartis, GMB honoraria from Novartis, BMS and Pfizer, THB research support from Novartis, MCM grants and honoraria from Novartis, BMS, Ariad and Pfizer, AB honoraria from BMS, JM research support from Novartis and BMS, HL honoraria from Novartis, PS honoraria from Novartis, BMS, Pfizer and Ariad, CS honoraria from Novartis, AH research support from Novartis and honoraria from Novartis, BMS and Pfizer; all other authors reported no conflict of interest.